Truist Financial
TAK icon

Truist Financial’s Takeda Pharmaceutical TAK Stock Holding History

Truist Financial’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
71,842
+2,010
+3% +$33.3K ﹤0.01% 1681
2026
Q1 		$1.29M Buy
69,832
+4,688
+7% +$82.3K ﹤0.01% 1570
2025
Q4 		$1.02M Buy
65,144
+3,719
+6% +$53.2K ﹤0.01% 1656
2025
Q3 		$899K Sell
61,425
-3,712
-6% -$55.1K ﹤0.01% 1723
2025
Q2 		$1.01M Sell
65,137
-1,537
-2% -$22.7K ﹤0.01% 1594
2025
Q1 		$991K Sell
66,674
-3,257
-5% -$45.6K ﹤0.01% 1519
2024
Q4 		$926K Sell
69,931
-14,525
-17% -$200K ﹤0.01% 1585
2024
Q3 		$1.2M Sell
84,456
-43,432
-34% -$616K ﹤0.01% 1441
2024
Q2 		$1.65M Sell
127,888
-6,998
-5% -$92.6K ﹤0.01% 1357
2024
Q1 		$1.87M Sell
134,886
-72,933
-35% -$1.06M ﹤0.01% 1311
2023
Q4 		$2.97M Sell
207,819
-36,574
-15% -$519K ﹤0.01% 1069
2023
Q3 		$3.78M Sell
244,393
-5,645
-2% -$87.4K 0.01% 948
2023
Q2 		$3.93M Buy
250,038
+9,955
+4% +$163K 0.01% 930
2023
Q1 		$3.96M Buy
240,083
+73,984
+45% +$1.18M 0.01% 920
2022
Q4 		$2.59M Buy
166,099
+87,266
+111% +$1.22M ﹤0.01% 1079
2022
Q3 		$1.02M Sell
78,833
-6,522
-8% -$90.7K ﹤0.01% 1484
2022
Q2 		$1.2M Buy
85,355
+4,824
+6% +$68.9K ﹤0.01% 1452
2022
Q1 		$1.15M Sell
80,531
-2,438
-3% -$35.8K ﹤0.01% 1562
2021
Q4 		$1.13M Sell
82,969
-10,577
-11% -$148K ﹤0.01% 1565
2021
Q3 		$1.53M Sell
93,546
-2,065
-2% -$34.7K ﹤0.01% 1398
2021
Q2 		$1.61M Buy
95,611
+22,855
+31% +$389K ﹤0.01% 1403
2021
Q1 		$1.33M Sell
72,756
-11,597
-14% -$209K ﹤0.01% 1421
2020
Q4 		$1.53M Sell
84,353
-13,541
-14% -$238K ﹤0.01% 1293
2020
Q3 		$1.75M Sell
97,894
-20,528
-17% -$374K ﹤0.01% 1126
2020
Q2 		$2.12M Sell
118,422
-17,161
-13% -$308K ﹤0.01% 1002
2020
Q1 		$2.06M Sell
135,583
-16,468
-11% -$298K 0.01% 971
2019
Q4 		$3M Buy
152,051
+40,637
+36% +$777K 0.01% 961
2019
Q3 		$1.92M Buy
111,414
+5,398
+5% +$93.4K 0.03% 364
2019
Q2 		$1.88M Buy
106,016
+14,563
+16% +$265K 0.03% 365
2019
Q1 		$1.86M Buy
91,453
+29,105
+47% +$586K 0.03% 361
2018
Q4 		$1.05M Buy
+62,348
New +$1.05M 0.02% 441

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Truist Financial's TAK Position: Q2 2026 in Review

Truist Financial increased its Takeda Pharmaceutical (TAK) stake by 2.9% in Q2 2026, buying an estimated $33.3K and bringing the position to 71,842 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

Truist Financial first reported a position in TAK in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.96M in Q1 2023. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Truist Financial held 71,842 shares of Takeda Pharmaceutical worth $1.15M as of Q2 2026.
  • Truist Financial bought 2,010 Takeda Pharmaceutical shares in Q2 2026, an estimated $33.3K.
  • Takeda Pharmaceutical made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1681 holding.
  • Truist Financial first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
  • Truist Financial's Takeda Pharmaceutical position peaked at $3.96M in Q1 2023.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.